Peter Damman

Correction to: Combined strategy of upfront CTCA and optimal treatment for stable chest pain: rationale and design of the CLEAR-CAD trial.

Journal: Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation

Published: August 12, 2026

Vericiguat for the treatment of coronary vasospasm (ViVA): a double-blind placebo-controlled randomized cross-over trial.

Journal: Journal of the American College of Cardiology

Published: July 21, 2026

Prevalence of vasomotor dysfunction in patients with residual or recurrent angina after percutaneous coronary intervention.

Journal: EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology

Published: July 20, 2026

Long-term clinical outcomes of high-risk plaques with negative fractional flow reserve: the PECTUS-obs study.

Journal: EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology

Published: May 27, 2026

Long-Term Clinical Outcomes of High-Risk Plaques with Negative fractional flow reserve: the PECTUS-obs study.

Journal: EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology

Published: May 27, 2026

Ticagrelor monotherapy versus dual antiplatelet therapy after primary percutaneous coronary intervention: one-year outcomes of the pilot STOP-IMH randomised trial.

Journal: EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology

Published: May 27, 2026

Patients with angina and non-obstructive coronary artery disease undergoing comprehensive invasive coronary function testing: long-term clinical outcomes.

Journal: European heart journal

Published: May 06, 2026

International study of coronary microvascular angina (iCorMicA): A registry-based diagnostic study and nested randomized trial.

Journal: American heart journal

Published: April 28, 2026

International study of Coronary Microvascular Angina (iCorMicA): a registry-based diagnostic study and nested randomized trial.

Journal: American heart journal

Published: April 28, 2026

Lipid-lowering therapy omission at discharge and one-year outcomes after percutaneous coronary intervention: a real-world analysis of overall and elderly patients.

Journal: International journal of cardiology. Heart & vasculature

Published: April 22, 2026

Correction to: Combined strategy of upfront CTCA and optimal treatment for stable chest pain: rationale and design of the CLEAR-CAD trial.

Correction to: Combined strategy of upfront CTCA and optimal treatment for stable chest pain: rationale and design of the CLEAR-CAD trial.

Vericiguat for the treatment of coronary vasospasm (ViVA): a double-blind placebo-controlled randomized cross-over trial.

Vericiguat for the treatment of coronary vasospasm (ViVA): a double-blind placebo-controlled randomized cross-over trial.

Prevalence of vasomotor dysfunction in patients with residual or recurrent angina after percutaneous coronary intervention.

Prevalence of vasomotor dysfunction in patients with residual or recurrent angina after percutaneous coronary intervention.

Long-term clinical outcomes of high-risk plaques with negative fractional flow reserve: the PECTUS-obs study.

Long-term clinical outcomes of high-risk plaques with negative fractional flow reserve: the PECTUS-obs study.

Long-Term Clinical Outcomes of High-Risk Plaques with Negative fractional flow reserve: the PECTUS-obs study.

Long-Term Clinical Outcomes of High-Risk Plaques with Negative fractional flow reserve: the PECTUS-obs study.

Ticagrelor monotherapy versus dual antiplatelet therapy after primary percutaneous coronary intervention: one-year outcomes of the pilot STOP-IMH randomised trial.

Ticagrelor monotherapy versus dual antiplatelet therapy after primary percutaneous coronary intervention: one-year outcomes of the pilot STOP-IMH randomised trial.

Feasibility of endothelial cell isolation from routine coronary function testing in ANOCA patients.

Feasibility of endothelial cell isolation from routine coronary function testing in ANOCA patients.

Feasibility of endothelial cell isolation from routine coronary function testing in ANOCA patients.

Feasibility of endothelial cell isolation from routine coronary function testing in ANOCA patients.

Patients with angina and non-obstructive coronary artery disease undergoing comprehensive invasive coronary function testing: long-term clinical outcomes.

Patients with angina and non-obstructive coronary artery disease undergoing comprehensive invasive coronary function testing: long-term clinical outcomes.

International study of coronary microvascular angina (iCorMicA): A registry-based diagnostic study and nested randomized trial.

International study of coronary microvascular angina (iCorMicA): A registry-based diagnostic study and nested randomized trial.

International study of Coronary Microvascular Angina (iCorMicA): a registry-based diagnostic study and nested randomized trial.

International study of Coronary Microvascular Angina (iCorMicA): a registry-based diagnostic study and nested randomized trial.

Lipid-lowering therapy omission at discharge and one-year outcomes after percutaneous coronary intervention: a real-world analysis of overall and elderly patients.

Lipid-lowering therapy omission at discharge and one-year outcomes after percutaneous coronary intervention: a real-world analysis of overall and elderly patients.